# Worksport Ltd: financial statements, quarterly

WKSP · Nasdaq · CIK 1096275 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wksp.md) · [Financials](/companies/wksp/financials.md) · [Filings](/companies/wksp/filings.md) · [Insiders](/companies/wksp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wksp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [458](/filings/0001493152-24-045105.md) | [839 d](/filings/0001641172-25-000850.md) | [513](/filings/0001641172-25-010837.md) | [1,922](/filings/0001641172-25-023334.md) | [3,122](/filings/0001493152-25-022113.md) | [2,928 d](/filings/0001493152-26-012945.md) | [2,240](/filings/0001493152-26-022706.md) | [4,105](/filings/0001437749-26-026997.md) | [5,014](/filings/0001493152-25-022113.md) | [4,743 d](/filings/0001493152-26-012945.md) | [3,313](/filings/0001493152-26-022706.md) | [5,230](/filings/0001437749-26-026997.md) |
| Cost of revenue | $k | [369](/filings/0001493152-24-045105.md) | [747 d](/filings/0001641172-25-000850.md) | [475](/filings/0001641172-25-010837.md) | [1,625](/filings/0001641172-25-023334.md) | [2,875](/filings/0001493152-25-022113.md) | [2,603 d](/filings/0001493152-26-012945.md) | [1,844](/filings/0001493152-26-022706.md) | [3,023](/filings/0001437749-26-026997.md) | [3,445](/filings/0001493152-25-022113.md) | [3,315 d](/filings/0001493152-26-012945.md) | [2,459](/filings/0001493152-26-022706.md) | [3,580](/filings/0001437749-26-026997.md) |
| Gross profit | $k | [89.7](/filings/0001493152-24-045105.md) | [92.1 d](/filings/0001641172-25-000850.md) | [37.5](/filings/0001641172-25-010837.md) | [297](/filings/0001641172-25-023334.md) | [247](/filings/0001493152-25-022113.md) | [324 d](/filings/0001493152-26-012945.md) | [396](/filings/0001493152-26-022706.md) | [1,082](/filings/0001437749-26-026997.md) | [1,569](/filings/0001493152-25-022113.md) | [1,428 d](/filings/0001493152-26-012945.md) | [854](/filings/0001493152-26-022706.md) | [1,650](/filings/0001437749-26-026997.md) |
| Research and development | $k | not reported | not reported | [381](/filings/0001641172-25-010837.md) | [1,046](/filings/0001641172-25-023334.md) | [396](/filings/0001493152-25-022113.md) | [478 d](/filings/0001493152-26-012945.md) | [370](/filings/0001493152-26-022706.md) | [305](/filings/0001437749-26-026997.md) | [301](/filings/0001493152-25-022113.md) | [563 d](/filings/0001493152-26-012945.md) | [205](/filings/0001493152-26-022706.md) | [214](/filings/0001437749-26-026997.md) |
| Selling, general and administrative | $k | not reported | not reported | [3,294](/filings/0001641172-25-010837.md) | [3,975](/filings/0001641172-25-023334.md) | [3,748](/filings/0001493152-25-022113.md) | [3,601 d](/filings/0001493152-26-012945.md) | [4,208](/filings/0001493152-26-022706.md) | [4,256](/filings/0001437749-26-026997.md) | [5,891](/filings/0001493152-25-022113.md) | [7,083 d](/filings/0001493152-26-012945.md) | [6,172](/filings/0001493152-26-022706.md) | [5,049](/filings/0001437749-26-026997.md) |
| Operating income | $k | [(3,920)](/filings/0001493152-24-045105.md) | [(3,548) d](/filings/0001641172-25-000850.md) | [(3,639)](/filings/0001641172-25-010837.md) | [(3,911)](/filings/0001641172-25-023334.md) | [(3,905)](/filings/0001493152-25-022113.md) | [(4,010) d](/filings/0001493152-26-012945.md) | [(4,256)](/filings/0001493152-26-022706.md) | [(3,618)](/filings/0001437749-26-026997.md) | [(4,793)](/filings/0001493152-25-022113.md) | [(6,130) d](/filings/0001493152-26-012945.md) | [(5,744)](/filings/0001493152-26-022706.md) | [(3,819)](/filings/0001437749-26-026997.md) |
| Interest expense | $k | [114](/filings/0001493152-23-041264.md) | [149 d](/filings/0001493152-24-011808.md) | [124](/filings/0001493152-24-020125.md) | [134](/filings/0001641172-25-023334.md) | [230](/filings/0001493152-25-022113.md) | [239 d](/filings/0001493152-26-012945.md) | [195](/filings/0001493152-26-022706.md) | [128](/filings/0001437749-26-026997.md) | [139](/filings/0001493152-25-022113.md) | [130 d](/filings/0001493152-26-012945.md) | [92.4](/filings/0001493152-26-022706.md) | [147](/filings/0001437749-26-026997.md) |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(3,949)](/filings/0001493152-24-045105.md) | [(3,659) d](/filings/0001641172-25-000850.md) | [(3,715)](/filings/0001641172-25-010837.md) | [(4,013)](/filings/0001641172-25-023334.md) | [(4,135)](/filings/0001493152-25-022113.md) | [8,148 d](/filings/0001641172-25-010837.md) | [(4,460)](/filings/0001493152-26-022706.md) | [(3,734)](/filings/0001437749-26-026997.md) | [(4,929)](/filings/0001493152-25-022113.md) | [(6,229) d](/filings/0001493152-26-012945.md) | [(5,829)](/filings/0001493152-26-022706.md) | [(3,965)](/filings/0001437749-26-026997.md) |
| Diluted EPS | $ per share | [(0.23)](/filings/0001493152-24-045105.md) | not reported | [(1.75)](/filings/0001641172-25-010837.md) | [(1.55)](/filings/0001641172-25-023334.md) | [(1.40)](/filings/0001493152-25-022113.md) | not reported | [(1.05)](/filings/0001493152-26-022706.md) | [(0.71)](/filings/0001437749-26-026997.md) | [(0.75)](/filings/0001493152-25-022113.md) | not reported | [(0.54)](/filings/0001493152-26-022706.md) | [(0.33)](/filings/0001437749-26-026997.md) |
| Basic EPS | $ per share | [(0.23)](/filings/0001493152-24-045105.md) | not reported | [(1.75)](/filings/0001641172-25-010837.md) | [(1.55)](/filings/0001641172-25-023334.md) | [(1.40)](/filings/0001493152-25-022113.md) | not reported | [(1.05)](/filings/0001493152-26-022706.md) | [(0.71)](/filings/0001437749-26-026997.md) | [(0.75)](/filings/0001493152-25-022113.md) | not reported | [(0.54)](/filings/0001493152-26-022706.md) | [(0.33)](/filings/0001437749-26-026997.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.0](/filings/0001493152-23-041264.md) | [3.4](/filings/0001641172-25-000850.md) | [3.5](/filings/0001493152-24-020125.md) | [3.4](/filings/0001493152-24-031589.md) | [1.9](/filings/0001493152-24-045105.md) | [4.9](/filings/0001493152-26-012945.md) | [5.1](/filings/0001641172-25-010837.md) | [1.4](/filings/0001641172-25-023334.md) | [3.8](/filings/0001493152-25-022113.md) | [5.9](/filings/0001437749-26-026997.md) | [0.6](/filings/0001493152-26-022706.md) | [1.2](/filings/0001437749-26-026997.md) |
| Current assets | $m | [7.9](/filings/0001493152-23-041264.md) | [9.1](/filings/0001641172-25-000850.md) | [10.7](/filings/0001493152-24-020125.md) | [10.7](/filings/0001493152-24-031589.md) | [8.9](/filings/0001493152-24-045105.md) | [10.5](/filings/0001493152-26-012945.md) | [11.5](/filings/0001641172-25-010837.md) | [8.5](/filings/0001641172-25-023334.md) | [12.4](/filings/0001493152-25-022113.md) | [16.8](/filings/0001437749-26-026997.md) | [13.5](/filings/0001493152-26-022706.md) | [14.9](/filings/0001437749-26-026997.md) |
| Total assets | $m | [24.6](/filings/0001493152-23-041264.md) | [26.0](/filings/0001641172-25-000850.md) | [27.3](/filings/0001493152-24-020125.md) | [27.2](/filings/0001493152-24-031589.md) | [24.9](/filings/0001493152-24-045105.md) | [25.7](/filings/0001493152-26-012945.md) | [26.7](/filings/0001641172-25-010837.md) | [23.6](/filings/0001641172-25-023334.md) | [27.0](/filings/0001493152-25-022113.md) | [30.7](/filings/0001437749-26-026997.md) | [27.9](/filings/0001493152-26-022706.md) | [28.1](/filings/0001437749-26-026997.md) |
| Current liabilities | $m | [7.6](/filings/0001493152-23-041264.md) | [7.2](/filings/0001641172-25-000850.md) | [7.8](/filings/0001493152-24-020125.md) | [2.3](/filings/0001493152-24-031589.md) | [3.0](/filings/0001493152-24-045105.md) | [3.2](/filings/0001493152-26-012945.md) | [3.5](/filings/0001641172-25-010837.md) | [3.7](/filings/0001641172-25-023334.md) | [6.1](/filings/0001493152-25-022113.md) | [6.7](/filings/0001437749-26-026997.md) | [6.9](/filings/0001493152-26-022706.md) | [3.9](/filings/0001437749-26-026997.md) |
| Total liabilities | $m | [8.2](/filings/0001493152-23-041264.md) | [7.8](/filings/0001641172-25-000850.md) | [8.4](/filings/0001493152-24-020125.md) | [8.0](/filings/0001493152-24-031589.md) | [8.6](/filings/0001493152-24-045105.md) | [8.3](/filings/0001493152-26-012945.md) | [6.5](/filings/0001641172-25-010837.md) | [6.3](/filings/0001641172-25-023334.md) | [7.3](/filings/0001493152-25-022113.md) | [7.8](/filings/0001437749-26-026997.md) | [7.9](/filings/0001493152-26-022706.md) | [9.0](/filings/0001437749-26-026997.md) |
| Long-term debt | $m | not reported | [5.3](/filings/0001641172-25-000850.md) | not reported | not reported | not reported | [5.3](/filings/0001493152-26-012945.md) | [3.1](/filings/0001641172-25-010837.md) | [2.5](/filings/0001641172-25-023334.md) | [2.9](/filings/0001493152-25-022113.md) | [1.0](/filings/0001437749-26-026997.md) | [3.4](/filings/0001493152-26-022706.md) | [5.0](/filings/0001437749-26-026997.md) |
| Current portion of debt | $m | not reported | [5.3](/filings/0001641172-25-000850.md) | not reported | not reported | [0.2](/filings/0001493152-24-045105.md) | [0.2](/filings/0001493152-26-012945.md) | [0.2](/filings/0001641172-25-010837.md) | [0.2](/filings/0001641172-25-023334.md) | [1.8](/filings/0001493152-25-022113.md) | [1.7](/filings/0001437749-26-026997.md) | [2.5](/filings/0001493152-26-022706.md) | [0.3](/filings/0001437749-26-026997.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [16.4](/filings/0001493152-24-045105.md) | [18.2](/filings/0001493152-26-012945.md) | [18.9](/filings/0001641172-25-023334.md) | [19.1](/filings/0001493152-25-022113.md) | [16.4](/filings/0001493152-25-022113.md) | [17.4](/filings/0001437749-26-026997.md) | [20.1](/filings/0001437749-26-026997.md) | [17.3](/filings/0001437749-26-026997.md) | [19.8](/filings/0001493152-25-022113.md) | [22.9](/filings/0001437749-26-026997.md) | [20.0](/filings/0001437749-26-026997.md) | [19.1](/filings/0001437749-26-026997.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,176) d](/filings/0001493152-24-045105.md) | [(3,736) d](/filings/0001641172-25-000850.md) | [(2,795)](/filings/0001641172-25-010837.md) | [(3,627) d](/filings/0001641172-25-023334.md) | [(1,538) d](/filings/0001493152-25-022113.md) | [(2,180) d](/filings/0001493152-26-012945.md) | [(3,840)](/filings/0001493152-26-022706.md) | [(3,095) d](/filings/0001437749-26-026997.md) | [(4,255) d](/filings/0001493152-25-022113.md) | [(6,124) d](/filings/0001493152-26-012945.md) | [(8,235)](/filings/0001493152-26-022706.md) | [(3,442) d](/filings/0001437749-26-026997.md) |
| Capital expenditure | $k | [849 d](/filings/0001493152-24-045105.md) | [244 d](/filings/0001641172-25-000850.md) | [213](/filings/0001641172-25-010837.md) | [123 d](/filings/0001641172-25-023334.md) | [165 d](/filings/0001493152-25-022113.md) | [27.5 d](/filings/0001493152-26-012945.md) | [201](/filings/0001493152-26-022706.md) | [68.4 d](/filings/0001437749-26-026997.md) | [364 d](/filings/0001493152-25-022113.md) | [155 d](/filings/0001493152-26-012945.md) | [104](/filings/0001493152-26-022706.md) | [68.5 d](/filings/0001437749-26-026997.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.2](/filings/0001493152-23-041264.md) | [17.2](/filings/0001493152-24-020125.md) | [17.2](/filings/0001493152-24-031589.md) | [17.4](/filings/0001493152-24-045105.md) | [2.1](/filings/0001641172-25-010837.md) | [2.6](/filings/0001641172-25-023334.md) | [2.9](/filings/0001493152-25-022113.md) | [4.3](/filings/0001493152-26-022706.md) | [5.3](/filings/0001437749-26-026997.md) | [6.6](/filings/0001493152-25-022113.md) | [10.8](/filings/0001493152-26-022706.md) | [11.9](/filings/0001437749-26-026997.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 15,298,333 at 2026-08-11, from the cover of the [10-Q filed 2026-08-11](/filings/0001437749-26-026997.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.